MicroHemp is a specialized plant tissue culture laboratory operating in support of the European medicinal cannabis supply chain, with a focus on high-integrity genetic propagation and management for regulated environments.

We specialize in the production of Gen 0 clones through in-vitro micropropagation, supplying clean, vigorous, and genetically stable starting material designed for cultivation systems aligned with EU-GACP and EU-GAP. requirements. 

Our propagation protocols emphasize phytosanitary control, genetic fidelity, traceability, and batch-to-batch reproducibility—key prerequisites for medicinal cannabis production intended for pharmaceutical processing.

In addition to propagation, MicroHemp delivers Genetics as a Service, supporting pharmaceutical companies, licensed producers, and research institutions in the controlled lifecycle management of cannabis genetics. Services include genetic recovery and stabilization, pathogen sanitation, clonal uniformity programs, cultivar optimization, and long-term in-vitro conservation. This enables partners to preserve, protect, and scale valuable genetics within compliant and auditable production frameworks.

All activities are conducted in controlled laboratory environments and structured around standardized procedures, documentation practices, and quality principles compatible with EU regulated markets and downstream EU-GMP manufacturing interfaces. Our approach is designed to reduce biological variability, mitigate risk, and ensure long-term genetic continuity across medicinal cannabis programs.

MicroHemp partners with pharmaceutical operators and EU-licensed stakeholders seeking scientific rigor, regulatory awareness, and reliability in the propagation and stewardship of medicinal cannabis genetics.

MICROHEMP S.R.L.

Org chart

Teams

Offices